TC BioPharm plc reported a change in its American Depositary Shares (ADS) ratio from 1:200 to 1:4000, effective February 10, 2025, which is similar to a one-for-20 reverse ADS split. This did not affect the underlying ordinary shares and resulted in adjustments to associated public warrants.